Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 221-226 , September 2009

A preliminary study of protoporphyrin-IX as a potential candidate for identification of lung cancer cells using fluorescence microscopy

  • Dae-Sung Hyun, MD, PhD

      Affiliations

    • Department of Internal Medicine, School of Medicine, Catholic University of Taegu, South Korea
    • ,
  • Hong-Tae Kim, MD, PhD

      Affiliations

    • Department of Anatomy, School of Medicine, Catholic University of Taegu, South Korea
    • ,
  • Sang-Hoon Jheon, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Bundang Hospital, College of Medicine, Seoul National University, South Korea
    • ,
  • Seung-Il Park, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, College of Medicine, Ulsan University, South Korea
    • ,
  • Jong-Ki Kim, PhD

      Affiliations

    • Department of Biomedical Engineering, School of Medicine, Catholic University of Taegu, South Korea
    • Department of Radiology, School of Medicine, Catholic University of Taegu, South Korea
    • Corresponding Author InformationCorresponding author at: Radiology and Biomedical Engineering, Catholic University of Taegu, 3056-6 Taemyung 4 Dong, Nam-Ku, Taegu City 705-034, South Korea. Tel.: +82 53 650 4335; fax: +82 53 650 4335.

References 

  1. The International Early lung cancer Action Program (ELCAP) . Survival of patients with stage I lung cancer detected on CT screening. New Eng J of Med. 2006;355:1763–1771
  2. Moghissi K, Dixon K, Thorpe JAC, Stringer M, Oxtoby C. Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax. 2007;62:391–395
  3. Ost D, Photodynamic therapy in lung cancer: a review in lung cancer. In: Driscoll B, editor. Diagnostic and therapeutic methods, vol. 2, Methods Mol Med 75; 2002, 507–526.
  4. Cavaliere S, Foccoli P, Toninelli C, Feijo S. Nd:YAG laser therapy in lung cancer: an 11 year experience with 2253 application in 1585 patients. J Bronchol. 1994;1:105–111
  5. Van Boxem TJ, Venmans BJ, Schramel FM, et al. Radiographically occult lung cancer treated with fiberoptic bronchoscopic electrocautery: a pilot study of a simple and inexpernsive technique. Eur Respir J. 1998;11:169–172
  6. Hirsch FR, Franklin WA, Gasdar AF, Bunn PA. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 2001;7:5–22
  7. Russo P, Paleari L, Granone P, Cesario A, Pastorino U. Computed tomography screening for lung cancer in a high-risk population: update on current status. J Natl Cancer Inst. 2008;100:1043–1044
  8. Yee J, Sadar MD, Sin DD, et al. Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol. 2009;27:2787–2792
  9. Matthew B, Stanbrook MB, Flegel K. A pause for thought on lung cancer screening. Can Med Assoc J. 2009;180:793–1793
  10. Kennedy TC, Prindiville S. Screening for lung cancer revisited and the role of sputum cytology and fluorescence bronchoscopy in a high-risk group. Chest. 2000;117:72S–79S
  11. Lam B, Lam SY, Wong MP, et al. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer. 2009;4:289–294
  12. Gazdar AF, Minna JD. Molecular detection of early lung cancer. J Natl Cancer Inst. 1999;91:299–301
  13. van den Bergh H. Early detection of lung cancer and the role of endoscopic fluorescence imaging. Med Laser Appl. 2003;18:20–26
  14. Häuβinger K, Becker H, Stanzel F, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax. 2005;60:496–503
  15. Lee P, van den Berg RM, Lam S, et al. Color fluorescence ratio for detection of bronchial dysplasia and carcinoma in situ. Clin Cancer Res. 2009;15:4700–4705
  16. Steven FS, Payne PW, Palcic B, Katsumi T, Kato H. Fluorescent location of lung tumour cells. Anticancer Res. 1998;18:3323–3326
  17. Steven FS, Payne PW, Palcic B. Fluorescent location of malignant cells in smears obtained from sputum. Anticancer Res. 1994;14:2021–2024
  18. Steven FS, Payne PW, Palcic B, Katsumi T. Sputum cells from lung tumor patients carry a cell surface marker not found in normal sputum. Anticancer Res. 1998;18:3855–3858
  19. Cortese DA. Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer. Rev Respir Dis. 1982;126:1087–1099
  20. Kato H. Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation. Clin Chest Med. 1985;6:237–248
  21. Patel KB. Fluorescing cells in sputum after parenteral HPD, porphyrin localization and treatment of tumors. Prog Clin Biol Res. 1984;170:521–530
  22. University of Colorado at Denver and Health Sciences Center. Sputum cytology in screening heavy smokers for lung cancer, 2009 http://clinicaltrials.gov/ct2/show/NCT00103363.
  23. Hautmann H, Pichler JP, Stepp H, Baumgartner R, Gamarra F, Huber RM. In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Resp Res. 2007;8:33
  24. Piotrowski WJ, Marczak J, Nawrocka A, Antczak A, Gorski P. Inhalationsof 5-ALA in photodynamic diagnosis of bronchial cancer. Monaldi Arch Chest Dis. 2004;61:86–93
  25. Huber RM, Gamarra F, Hautmann H, Haubinger K, Wagner S, Castro M, et al. 5-Aminolaevulinic acid for the fluorescence detection of bronchial tumors. Diag Therap Endosc. 1999;5:113–118
  26. Leonhard M. New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diag Therap Endosc. 1999;5:71–75

PII: S1572-1000(09)00137-9

doi: 10.1016/j.pdpdt.2009.10.004

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 221-226 , September 2009

Article Tools

* Image Usage & Resolution